{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:35:45Z","timestamp":1791956145150,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1995,11,1]],"date-time":"1995-11-01T00:00:00Z","timestamp":815184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporosis Int"],"published-print":{"date-parts":[[1995,11]]},"DOI":"10.1007\/bf01626609","type":"journal-article","created":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T05:25:35Z","timestamp":1114925135000},"page":"462-466","source":"Crossref","is-referenced-by-count":36,"title":["Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone"],"prefix":"10.1007","volume":"5","author":[{"given":"D.","family":"Agnusdei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bufalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"14","volume":"76","author":"RR Recker","year":"1993","unstructured":"Recker RR. Current therapy for osteoporosis. J Clin Endocrinol Metab 1993;76:14\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00019053-199405050-00008","volume":"5","author":"R Whittington","year":"1994","unstructured":"Whittington R, Faulds D. Hormone replacement therapy. I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen-deficiency. Pharmaco-Economics 1994;5:419\u201345.","journal-title":"Pharmaco-Economics"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01624146","volume":"2","author":"T Naess\u00e9n","year":"1992","unstructured":"Naess\u00e9n T, Persson I, Ljunghall S, Bergstrom R. Women with climacteric symptoms: a target group for prevention of rapid bone loss and osteoporosis. Osteoporosis Int 1992;2:225\u201331.","journal-title":"Osteoporosis Int"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJM199310143291601","volume":"329","author":"DT Felson","year":"1993","unstructured":"Felson DT, Zhang Y, Hannan MT, et al. The effect of postmeno-pausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141\u20136.","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0002-9378(12)90897-2","volume":"168","author":"CS Field","year":"1993","unstructured":"Field CS, Ory SJ, Wahner HW, et al. Preventive effect of transdermal 17-beta estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial. Am J Obstet Gynecol 1993;168:114\u201321.","journal-title":"Am J Obstet Gynecol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0140-6736(90)91801-G","volume":"335","author":"JC Stevenson","year":"1990","unstructured":"Stevenson JC, Cust MP, Gangar KF, et al. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet 1990;335:265\u20139.","journal-title":"Lancet"},{"key":"CR7","first-page":"599","volume":"305","author":"MJ Whithead","year":"1981","unstructured":"Whithead MJ, Townsend PT, Pryse-Davies J, Ryder TA, King RJB. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 1981;305:599\u2013604.","journal-title":"N Engl J Med"},{"key":"CR8","first-page":"759","volume":"63","author":"R Lindsay","year":"1984","unstructured":"Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1984;63:759\u201363.","journal-title":"Obstet Gynecol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/oxfordjournals.bmb.a072552","volume":"48","author":"E Daly","year":"1992","unstructured":"Daly E, Roche M, Barlow D, et al. HRT: an analysis of benefits, risks and costs. Br Med Bull 1992;48:368\u2013400.","journal-title":"Br Med Bull"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/978-1-4471-1799-5_26","volume-title":"HRT and osteoporosis","author":"M Roche","year":"1990","unstructured":"Roche M, Vessey M. Hormone replacement therapy in the menopause: risks, benefits and costs. In Drife JO, Studd JWW, editors. HRT and osteoporosis. Berlin: Springer, 1990:363\u201372."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0024-3205(86)90591-6","volume":"38","author":"I Yamazaki","year":"1986","unstructured":"Yamazaki I. Effect of ipriflavone in the response of uterus and thyroid to estrogen. Life Sci 1986;38:757\u201364.","journal-title":"Life Sci"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/BF03347647","volume":"15","author":"GB Melis","year":"1992","unstructured":"Melis GB, Paoletti AM, Cagnacci A, et al. Lack of any estrogenic effect of ipriflavone in postmenopausal women. J Endocrinol Invest 1992;15:755\u201361.","journal-title":"J Endocrinol Invest"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/0024-3205(86)90492-3","volume":"38","author":"I Yamazaki","year":"1986","unstructured":"Yamazaki I, Kinoshita M. Calcitonin secretory property of ipriflavone in the presence of estrogen. Life Sci 1986;38:1535\u201341.","journal-title":"Life Sci"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/0169-6009(92)90865-B","volume":"19","author":"D Agnusdei","year":"1992","unstructured":"Agnusdei D, Adami S, Cervetti R, et al. Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis. Bone Miner 1992;19:S43\u20138.","journal-title":"Bone Miner"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF00305522","volume":"54","author":"M Valente","year":"1994","unstructured":"Valente M, Bufalino L, Castiglione GN, et al. Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass. Calcif Tissue Int 1994;54:377\u201380.","journal-title":"Calcif Tissue Int"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/009286159102500311","volume":"25","author":"D Gillings","year":"1991","unstructured":"Gillings D, Kock G. The application of the principle of intention to treat analysis of clinical trials. Drug Inform J 1991;25:441\u20134.","journal-title":"Drug Inform J"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","volume":"300","author":"JNS Matthews","year":"1990","unstructured":"Matthews JNS, Altman DG, Campbell MJ, Roystone P. Analysis of serial measurements in medical research. BMJ 1990;300:230\u20135.","journal-title":"BMJ"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1172\/JCI113056","volume":"80","author":"JC Stevenson","year":"1987","unstructured":"Stevenson JC, Banks LM, Spinks TJ. Regional and total skeletal measurements in the early postmenopause. J Clin Invest 1987;80:258\u201362.","journal-title":"J Clin Invest"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF03348848","volume":"16","author":"M Gambacciani","year":"1993","unstructured":"Gambacciani M, Spinetti A, Cappagli B, et al. Effects of ipriflavone administration on bone mass and metabolism and ovar\u00ecectom\u00eczed women. J Endocrinol Invest 1993;16:333\u20137.","journal-title":"J Endocrinol Invest"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0169-6009(08)80099-2","volume":"23","author":"JY Reginster","year":"1993","unstructured":"Reginster JY. Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis. Bone Miner 1993;23:223\u201332.","journal-title":"Bone Miner"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF00299315","volume":"55","author":"Su-Ling Cheng","year":"1994","unstructured":"Cheng Su-Ling, Zhang Shu-Fang, Nelson TL, Warlow PM, Civitelli R. Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites. Calcif Tissue Int 1994;55:356\u201362.","journal-title":"Calcif Tissue Int"},{"key":"CR22","first-page":"244","volume-title":"Osteoporosis 1993","author":"M Petilli","year":"1993","unstructured":"Petilli M, Frediani U, Benvenuti S, Bianchi S, Brandi ML. Lack of stereospecific interactions between ipriflavone and the estrogen receptor. In: Riis BJ, Christiansen C, editors. Osteoporosis 1993. Copenhagen: Osteopress ApS, 1993:244\u20135."}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01626609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01626609\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01626609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T10:53:53Z","timestamp":1557312833000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01626609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,11]]}},"alternative-id":["BF01626609"],"URL":"https:\/\/doi.org\/10.1007\/bf01626609","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,11]]}}}